ArticleBreast cancer research : BCR2024

A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer.

Mohamed Omar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.